A self-collection (SC) device that could easily be used at home proved safe and accurate for cervical screening in the SELF-CERV prospective nonrandomized clinical trial, as reported in JAMA Network Open.
Known as the Teal Wand, the device was recently approved by the US Food and Drug Administration (FDA) for home use.
When compared with clinician-collected (CC) samples, SC specimens showed high positive agreement for detecting high-risk human papillomavirus (hrHPV) as well as equivalent sensitivity for cervical dysplasia. The patient-friendly device proved safe and easy to use.
An at-home collection option is crucial to address clinic-related barriers to screening, according to Christine Conageski, MD, MSc, an associate professor of obstetrics and gynecology at University of Colorado Anschutz…